Literature DB >> 4555715

Fibrinolytic enhancement by stanozolol: a double blind trial.

J F Davidson, M Lochhead, G A McDonald, G P McNicol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4555715

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  15 in total

1.  Antifibrin action of phenformin.

Authors:  R N Banerjee; V Kumar; S R Rao; A L Sahni; M Arya; J Bardhan
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

2.  Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report.

Authors:  N L Browse; P E Jarrett; M Morland; K Burnand
Journal:  Br Med J       Date:  1977-08-13

3.  Jaundice induced by stanozolol hypersensitivity.

Authors:  S D Slater; J F Davidson; R S Patrick
Journal:  Postgrad Med J       Date:  1976-04       Impact factor: 2.401

4.  Fibrinolysis induced by danazol.

Authors:  S C Rizzo; G Grignani; G Gamba; G Nalli
Journal:  Blut       Date:  1986-10

5.  Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.

Authors:  P E Jarrett; M Morland; N L Browse
Journal:  Br Med J       Date:  1977-04-09

Review 6.  Familial venous thrombosis.

Authors:  J H Winter; A S Douglas
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

7.  The treatment of unexplained menorrhagia.

Authors:  E Cope
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

8.  The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblasts in vitro.

Authors:  J K Wright; A J Smith; T E Cawston; B L Hazleman
Journal:  Agents Actions       Date:  1989-11

9.  Effect of ethyloestrenol on fibrinolysis in the vessel wall.

Authors:  U Hedner; I M Nilsson; S Isacson
Journal:  Br Med J       Date:  1976-09-25

Review 10.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.